jujuboside-b and Sepsis

jujuboside-b has been researched along with Sepsis* in 1 studies

Other Studies

1 other study(ies) available for jujuboside-b and Sepsis

ArticleYear
Jujuboside B Inhibited High Mobility Group Box Protein 1-Mediated Severe Inflammatory Responses in Human Endothelial Cells and Mice.
    Journal of medicinal food, 2023, Volume: 26, Issue:1

    High mobility group box protein 1 (HMGB1) is a biomolecule that acts as an alerting signal of late sepsis by accelerating the production of proinflammatory cytokines, and eventually leads to various inflammation-related symptoms. When released into plasma at high concentration, it disrupts precise diagnosis and prognosis and worsens the survival of patients with systemic inflammatory conditions. Jujuboside B (JB) is a natural compound pressed from the seed of

    Topics: Animals; Cell Movement; HMGB1 Protein; Human Umbilical Vein Endothelial Cells; Humans; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Sepsis

2023